Vitamin d and Renovascular hypertension - a phase IV clinical study of FDA data
Renovascular hypertension is found among people who take Vitamin d, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Vitamin d and have Renovascular hypertension. It is created by eHealthMe based on reports of 224,762 people who have side effects when taking Vitamin d from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
224,762 people reported to have side effects when taking Vitamin d.
Among them, 18 people (0.01%) have Renovascular hypertension.
What is Vitamin d?
Vitamin d has active ingredients of ergocalciferol. It is often used in low vitamin d. eHealthMe is studying from 234,151 Vitamin d users for its effectiveness, alternative drugs and more.
What is Renovascular hypertension?
Renovascular hypertension (a syndrome which consists of high blood pressure caused by the kidneys hormonal response) is found to be associated with 435 drugs and 209 conditions by eHealthMe.
Number of Vitamin d and Renovascular hypertension reports submitted per year:
Time on Vitamin d when people have Renovascular hypertension *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 33.33 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 33.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 33.33 %
Gender of people who have Renovascular hypertension when taking Vitamin d *:
- female: 52.94 %
- male: 47.06 %
Age of people who have Renovascular hypertension when taking Vitamin d *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 11.76 %
- 40-49: 11.76 %
- 50-59: 35.29 %
- 60+: 41.18 %
Common drugs people take besides Vitamin d *:
- Prilosec: 12 people, 66.67%
- Nexium: 11 people, 61.11%
- Prilosec Otc: 10 people, 55.56%
- Prevacid: 9 people, 50.00%
- Protonix: 8 people, 44.44%
- Promethazine: 5 people, 27.78%
- Ondansetron: 4 people, 22.22%
- Heparin: 4 people, 22.22%
- Pepcid: 4 people, 22.22%
- Zolpidem: 4 people, 22.22%
Common side effects people have besides Renovascular hypertension *:
- Chronic Kidney Disease: 18 people, 100.00%
- Acute Kidney Failure: 12 people, 66.67%
- Nephrogenic Anaemia (anaemia due to kidney disease): 9 people, 50.00%
- Interstitial Nephritis (inflammation of the kidney): 5 people, 27.78%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
- Indigestion: 3 people, 16.67%
- Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 11.11%
- Renal Injury (kidney injury): 2 people, 11.11%
- Peripheral Vascular Disorder: 1 person, 5.56%
- Kidney Fibrosis (excess fibrous connective tissue in kidney): 1 person, 5.56%
Common conditions people have *:
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 100.00%
- Pain: 10 people, 55.56%
- High Blood Cholesterol: 9 people, 50.00%
- Renal Disorder (kidney disease): 6 people, 33.33%
- High Blood Pressure: 6 people, 33.33%
- Infection: 4 people, 22.22%
- Indigestion: 4 people, 22.22%
- Abdominal Discomfort: 4 people, 22.22%
- Swelling: 3 people, 16.67%
- Cardiac Disorder: 3 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Vitamin d and have Renovascular hypertension?Check whether Renovascular hypertension is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How severe was Renovascular hypertension and when was it recovered:
Expand to all the drugs that have ingredients of ergocalciferol:
Alternative drugs to, pros and cons of Vitamin d:
- Vitamin d (234,151 reports)
Common Vitamin d side effects:
Browse all side effects of Vitamin d:a b c d e f g h i j k l m n o p q r s t u v w x y z
Renovascular hypertension treatments and more:
- Renovascular hypertension (859 reports)
COVID vaccines that are related to Renovascular hypertension:
- Renovascular hypertension in Moderna COVID Vaccine
- Renovascular hypertension in Pfizer BioNTech Covid Vaccine
- Renovascular hypertension in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Renovascular hypertension:
- Renovascular hypertension (435 drugs)
Common conditions associated with Renovascular hypertension:
- Gastrooesophageal reflux disease: 104 reports
All the conditions that are associated with Renovascular hypertension:
- Renovascular hypertension (209 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol (the active ingredients of Vitamin d) and Vitamin d (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pantoprazole Sodium and Mobility Decreased - 26 seconds ago
- Gliclazide and Actemra drug interaction - 27 seconds ago
- Lamictal and Breast Discomfort - 29 seconds ago
- Pantoprazole Sodium and Ulcerative Colitis - a minute ago
- Miconazole Nitrate and Gatifloxacin drug interaction - a minute ago
- Guaifenesin and Stress Cardiomyopathy - 2 minutes ago
- Norditropin and Synthroid drug interaction - 2 minutes ago
- Peripheral Vascular Disorder and drugs of ingredients of aluminum hydroxide; magnesium trisilicate - 2 minutes ago
- Accuneb and Insomnia - 2 minutes ago
- Selzentry and Biktarvy drug interaction - 2 minutes ago